June 04, 2025
Member registration is now open for the 2025 AABB Annual Meeting, the blood and biotherapies field’s premier event. This year’s meeting will bring community members from throughout the world to San Diego, Oct. 25-28, to connect, network, learn and advance the field.
The 2025 AABB Annual Meeting’s General Session will be a celebration of the AABB community and will include a keynote address from Tom Whitehead, co-founder of the Emily Whitehead Foundation and father of the first pediatric patient to receive chimeric antigen receptor (CAR) T-cell therapy. In his remarks, Whitehead will reflect on his family’s experience navigating cancer and the life-saving impact of CAR T-cell therapy.
Immediately following the General Session, AABB will host the opening celebration of the Exhibit Hall, where industry partners will showcase the field’s latest innovations and solutions. The Exhibit Hall will also feature the AABB Learning Theater, offering corporate-sponsored presentations alongside short, informal sessions on timely topics in blood banking, transfusion medicine and biotherapies. The Biotherapies Pavilion will return as a dedicated space for those working in advanced therapies to meet, exchange ideas and explore new developments.
This year’s educational program will include expert-led sessions on emerging issues and core topics, blending new content with long-standing attendee favorites. AABB is also pleased to welcome Cord Blood Connect to the 2025 Annual Meeting, offering focused education and research on cord blood banking along with expanded opportunities to engage with experts in this area.
The Annual Meeting will continue to spotlight the latest practice-changing research. Highlights include guided tours of “Top Poster Award” recipients, an expanded lineup of oral abstract presentations and the return of abstract “spotlight sessions,” featuring leading voices examining key challenges and advances in transfusion medicine and biotherapies.